72 TENOFOVIR DISOPROXIL FUMARATE (TDF) FOR THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B: WEEK 72 TDF DATA AND WEEK 24 ADEFOVIR DIPIVOXIL SWITCH DATA (STUDY 103)

Journal article

Peer reviewed

J. Heathcote, J. George, S. Gordon, J.P. Bronowicki, J. Sperl, R. Williams, P. Martin, M. Beniowski, J. Sorbel, J. Anderson, …

Journal of hepatology, Vol.48, pp.S32-S32

2008-01

Metrics

2 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Industry collaboration; Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.125 Hepatitis; 1.125.275 HBV
Web Of Science research areas: Gastroenterology & Hepatology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: 72 TENOFOVIR DISOPROXIL FUMARATE (TDF) FOR THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B: WEEK 72 TDF DATA AND WEEK 24 ADEFOVIR DIPIVOXIL SWITCH DATA (STUDY 103)
Creators: J. Heathcote
J. George
S. Gordon
J.P. Bronowicki
J. Sperl
R. Williams
P. Martin
M. Beniowski
J. Sorbel
J. Anderson
E. Mondou
A. Snow
F. Rousseau
Publication Details: Journal of hepatology, Vol.48, pp.S32-S32
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hepatology
Language: English
Resource Type: Journal article
Record Identifier: 991031714317202976